Sponsor Pipeline

Shouyao Holdings (Beijing) Co. LTD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
2
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06254599 A Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With… Non-small Cell Lung Cancer Not Yet Recruiting
NCT06031558 Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or… Non-Small Cell Lung Cancer Active, Not Recruiting
Phase 1/2
NCT06970132 Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation Advanced Solid Tumor Not Yet Recruiting
Phase 1
NCT07469982 A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors Advanced or Metastatic Solid Tumors With Homozygous MTAP Deletion Recruiting
Disease Areas
Get alerts when Shouyao Holdings (Beijing) Co. LTD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free